Series C Life Science Companies

Cerevance is a biotechnology company that develops novel therapeutics for neurological diseases.

Colossal Biosciences is a biotechnology and genetic engineering company that uses gene editing technology to de-extinct species.

Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.

Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications.

Lumen Bio discovers, develops, and manufactures biologic drugs and vaccine candidates for various diseases.

Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.

Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.

Novelty Nobility is a private biotech company focused on the research of novel angiogenesis targets and develop antibody-based therapeutics.

GRA&GREEN is a biotechnology company that provides seed development for agriculture, forestry, and raw materials for food processing.

Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.

Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.

Unlearn.AI combines AI, digital twins, and novel statistical methods to enable smaller, more efficient clinical trials.

Kanaph Therapeutics is a leading biotech in oncology, auto-immune, and eye diseases with large molecules and small molecules.

Parse Biosciences is a biotechnology startup company that develops single-cell sequencing kit solutions for researchers.

4D Lifetec is a biotechnology company promoting and developing screening and test systems for molecular diagnostics.

KIYATEC utilizes the patient's own living tumor cells to create functional 3D models to test a battery of cancer therapies.

SCG Cell Therapy goal is to prevent and treat cancer by using the immune system of the patient to target pathogenic infections.

Ukko is a biotechnology company focused on developing immunotherapies for the treatment of allergies and other immune-mediated diseases.

Beacon Therapeutics is a biotechnology company that develops treatments to preserve and restore vision for rare and prevalent eye diseases.

Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers.